Literature DB >> 3555579

The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

H S Purba, J L Maggs, M L Orme, D J Back, B K Park.   

Abstract

The metabolism of 17 alpha-ethinyloestradiol (EE2) to catechol and reactive metabolites by human liver microsomes was investigated. 2-Hydroxyethinyloestradiol (2-OHEE2) was either the sole or principal metabolite. Small amounts of 6-hydroxyethinyloestradiol and 16-hydroxyethinyloestradiol were produced by some of the livers. EE2 (10 microM) underwent substantial (5-20% of incubated drug), though highly variable, NADPH-dependent metabolism to material irreversibly bound to microsomal protein. 2-OHEE2 appeared to be the pro-reactive metabolite. The maximum EE2 2-hydroxylase activity was 0.67 nmol min-1 mg-1 microsomal protein, with a Km value of 8.6 microM. Oestradiol, which is mainly hydroxylated to 2-hydroxyoestradiol, was the most potent inhibitor of hydroxylase activity and exhibited competitive inhibition. Progesterone, which undergoes 2-hydroxylation to a minor extent was also a competitive inhibitor, whereas cholesterol and cortisol did not have any appreciable inhibitory effect. Primaquine was the most potent non-steroidal inhibitor but was non-competitive. Other non-steroidal compounds investigated, e.g. antipyrine, did not show any significant effect on EE2 2-hydroxylation. The results of this study suggest that EE2 2-hydroxylation is metabolised by a form(s) of cytochrome P-450 which has affinity for endogenous steroids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3555579      PMCID: PMC1386094          DOI: 10.1111/j.1365-2125.1987.tb03074.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  32 in total

1.  The presence of dl-, d- and l-norgestrel and their metabolites in the plasma of women.

Authors:  S F Sisenwine; H B Kimmel; A L Liu; H W Ruelius
Journal:  Contraception       Date:  1975-09       Impact factor: 3.375

2.  The urinary metabolites of 17alpha-ethynylestradiol-9alpha,11xi-3H in women. Chromatographic profiling and indentification of ethynyl and non-ethynyl compounds.

Authors:  M C Williams; E D Helton; J W Goldzieher
Journal:  Steroids       Date:  1975-02       Impact factor: 2.668

3.  Cytochrome P-450-mediated oxidation of 2-hydroxyestrogens to reactive intermediates.

Authors:  S D Nelson; J R Mitchell; E Dybing; H A Sasame
Journal:  Biochem Biophys Res Commun       Date:  1976-06-21       Impact factor: 3.575

Review 4.  The catechol estrogens.

Authors:  N J MacLusky; F Naftolin; L C Krey; S Franks
Journal:  J Steroid Biochem       Date:  1981-12       Impact factor: 4.292

5.  Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase.

Authors:  H M Bolt; H Kappus
Journal:  J Steroid Biochem       Date:  1974-04       Impact factor: 4.292

6.  Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo.

Authors:  C F Wilkinson; K Hetnarski; G P Cantwell; F J Di Carlo
Journal:  Biochem Pharmacol       Date:  1974-09-01       Impact factor: 5.858

7.  Metabolism of 17 alpha-ethinylestradiol by human liver microsomes in vitro: aromatic hydroxylation and irreversible protein binding of metabolites.

Authors:  H M Bolt; H Kappus; R Käsbohrer
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

8.  Excretion of steroid hormones in adults. C19 and C21 steroids in faeces from pregnant women.

Authors:  H Eriksson; J A Gustafsson; J Sjövall
Journal:  Eur J Biochem       Date:  1970-02

9.  Effects of insecticide synergists on microsomal oxidation of estradiol and ethynylestradiol and on microsomal drug metabolism.

Authors:  H M Bolt; H Kassel
Journal:  Xenobiotica       Date:  1976-01       Impact factor: 1.908

10.  Cytochrome P-450 monooxygenase activities in human and rat liver microsomes.

Authors:  P Kremers; P Beaune; T Cresteil; J de Graeve; S Columelli; J P Leroux; J E Gielen
Journal:  Eur J Biochem       Date:  1981-09-01
View more
  32 in total

1.  Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.

Authors:  A P Li; N R Hartman; C Lu; J M Collins; J M Strong
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 2.  Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.

Authors:  P Glue; C R Banfield; J L Perhach; G G Mather; J K Racha; R H Levy
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 3.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

4.  The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.

Authors:  M D Tingle; M D Coleman; B K Park
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

5.  Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro.

Authors:  R J Riley; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

6.  Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.

Authors:  L Iyer; C D King; P F Whitington; M D Green; S K Roy; T R Tephly; B L Coffman; M J Ratain
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

7.  A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes.

Authors:  N R Kitteringham; C Lambert; J L Maggs; J Colbert; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-07       Impact factor: 4.335

8.  Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitors.

Authors:  H S Purba; D J Back; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

9.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

10.  Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751.

Authors:  Federico Innocenti; Jacqueline Ramírez; Jennifer Obel; Julia Xiong; Snezana Mirkov; Yi-Lin Chiu; David A Katz; Robert A Carr; Wei Zhang; Soma Das; Araba Adjei; Ann M Moyer; Pei Xian Chen; Andrew Krivoshik; Diane Medina; Gary B Gordon; Mark J Ratain; Leonardo Sahelijo; Richard M Weinshilboum; Gini F Fleming; Anahita Bhathena
Journal:  Pharmacogenet Genomics       Date:  2013-07       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.